NCT06136897 2026-04-13Testing Trastuzumab and Pertuzumab in Patients With Higher Than Normal Copies of the HER2 Gene Found in Their Tumors (MATCH - Subprotocol J)National Cancer Institute (NCI)Phase 2 Active not recruiting35 enrolled 10 charts